Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|April 13, 2021
Zonisamide as treatment option in persistent migraine auraKatharina Kaltseis, Florian Frank, Gregor Broessner
Frontiers in Neurology|October 7, 2022
Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1)Katharina Kaltseis, Elisabetta Indelicato, Gregor Broessner, et al.
Frontiers in Neurology|August 15, 2022
Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic ChallengeFlorian Frank, Katharina Kaltseis, Karl Messlinger, et al.
Frontiers in Physiology|September 23, 2022
Hypoxia-related mechanisms inducing acute mountain sickness and migraineFlorian Frank, Katharina Kaltseis, Vera Filippi, et al.
BMC Neurology|April 28, 2023
Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case seriesKatharina Kaltseis, Vera Filippi, Florian Frank, et al.
International Journal of Molecular Sciences|November 9, 2024
Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke-A ReviewMichael Thomas Eller, Florian Frank, Katharina Kaltseis, et al.
Neurology|June 19, 2025
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A ReviewMichael Thomas Eller, Katarína Schwarzová, Lena Gufler, et al.
Cephalalgia : an International Journal of Headache|March 25, 2022
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-StudyKatharina Kaltseis, Florian Frank, Benoît Bernar, et al.
Pageof 2